Strategic Research Centre for Cardiovascular and Metabolic Medicine
- Reference number
- A3 05:188
- Start and end dates
- 060101-121231
- Amount granted
- 55 000 000 SEK
- Administrative organization
- Göteborg University
- Research area
- Life Sciences
Summary
Metabolic syndrome is characterised by abdominal obesity, insulin resistance, and high cholesterol levels. Individuals with metabolic syndrome have a dramatically increased risk of developing cardiovascular disease. This syndrome affects one in four adults, making it the leading public health issue associated with cardiovascular disease the primary cause of death and disability worldwide. The centre is based on partnerships between clinical and basic medical sciences, bioinformatics and applied mathematics, and a close interaction with industry. Such partnerships should stimulate highly innovative interdisciplinary research and build networks between research communities of different traditions and cultures. The centre integrates many unique resources, such as: well-defined patient populations, comprehensive bio banks, state-of-the-art technologies for in vivo kinetic studies and phenotyping of human subjects, powerful platforms for human genetics and expression analyses, mouse genetics techniques and biochemistry and experimental cellular biology. The centre also integrates the nearby SweGene core facilities for functional proteomics, high-throughput genomics, bio-imaging, and cellular imaging. A major goal of the centre is to help young scientists and physician-scientists acquire all the necessary skills needed to launch successful careers in translational medicine.